News & Analysis as of September 21, 2024

Patient Protection and Affordable Care Act (PPACA) › Patent Litigation

+ Follow

The Patient Protection and Affordable Care Act (PPAC), also known as Obamacare, is a United States federal statute passed in March of 2010. The Act creates a nationwide insurance system and provides federal... more +

Building on Successful Judicial Assignment Reform in Texas

Troutman Pepper on 7/21/2023

More than 16 months ago, the two ranking members of the Senate Judiciary Committee asked Chief Justice John Roberts to direct the Judicial Conference of the United States to study forum shopping in patent litigation,...more

FDA Biosimilar Approval Recap – 2021

McDonnell Boehnen Hulbert & Berghoff LLP on 1/6/2022

The U.S. Food and Drug Administration approved four biosimilar drugs in 2021 under the provisions of the Biologics Price Competition and Innovation Act (BPCIA, codified at 42 U.S.C. § 262) as part of the Affordable Care Act...more

Supreme Court Developments

Skadden, Arps, Slate, Meagher & Flom LLP on 4/30/2021

Even as President Biden has appointed a commission to study potential institutional reforms of the U.S. Supreme Court, his administration’s most immediate impact at the Court came through a flurry of filings early this year...more

Legal Developments to Keep an Eye Out for in 2020

Goodwin on 1/6/2020

Here are our picks of some legal developments to keep an eye out for in the new year: Federal Circuit Decisions on Bevacizumab and Trastuzumab Preliminary Injunctions: Appeals are pending on the District of Delaware’s...more

100 Days Plus Under Trump: What They Mean for Biologics

Patterson Belknap Webb & Tyler LLP on 5/15/2017

President Donald J. Trump has now been in office for just over one hundred days. Observers have been quick to mark this milestone and assess the new administration’s performance, especially on headline-grabbing issues like...more

Post-Grant Challenges in Life Sciences: A Midyear Assessment

Troutman Pepper on 10/5/2015

The America Invents Act established inter partes review and post-grant reviews mechanisms to challenge the validity of issued United States patents. These procedures were created to improve patent quality, and were introduced...more

Expect Focus - Regulators Are Watching: New Products, New Opportunities, New Risks - Volume III, Summer 2014

Carlton Fields on 9/30/2014

In This Issue: - IN THE SPOTLIGHT ..Standard CGL Policy Form Adds Data Breach Coverage Exclusion - LIFE INSURANCE ..Class Claims Against Lincoln National Barred in Section 419 Action – Again ...more

7 Results

View per page

Page: of 1